Navigating the Evolving Treatment Landscape in HER2-mutated NSCLC - Episode 1
A panel of thoracic oncologists introduce themselves and discuss biomarker testing strategies and the diagnosis of HER2-mutated non–small cell lung cancer (NSCLC).